0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Therapy Manufacturing Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-8C13290
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell Therapy Manufacturing Market Research Report 2023
BUY CHAPTERS

Global Cell Therapy Manufacturing Market Research Report 2025

Code: QYRE-Auto-8C13290
Report
January 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell Therapy Manufacturing Market

The global market for Cell Therapy Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cell Therapy Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell Therapy Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell Therapy Manufacturing in Clinical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell Therapy Manufacturing include Merck, Avantor, Cell Therapies, Thermo Fisher Scientific, Charles River Laboratories, Catalent, Bio-Techne, Cytiva, Lonza, BIOCENTRIQ, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Therapy Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy Manufacturing.
The Cell Therapy Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Therapy Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Therapy Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell Therapy Manufacturing Market Report

Report Metric Details
Report Name Cell Therapy Manufacturing Market
Segment by Type
Segment by Application
  • Clinical
  • Commercial
  • Pre-clinical
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Avantor, Cell Therapies, Thermo Fisher Scientific, Charles River Laboratories, Catalent, Bio-Techne, Cytiva, Lonza, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Novartis, Bristol-Myers Squibb, Gilead, WuXi AppTec, Pharmaron, Aldevron, Exothera
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell Therapy Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell Therapy Manufacturing Market report?

Ans: The main players in the Cell Therapy Manufacturing Market are Merck, Avantor, Cell Therapies, Thermo Fisher Scientific, Charles River Laboratories, Catalent, Bio-Techne, Cytiva, Lonza, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Novartis, Bristol-Myers Squibb, Gilead, WuXi AppTec, Pharmaron, Aldevron, Exothera

What are the Application segmentation covered in the Cell Therapy Manufacturing Market report?

Ans: The Applications covered in the Cell Therapy Manufacturing Market report are Clinical, Commercial, Pre-clinical

What are the Type segmentation covered in the Cell Therapy Manufacturing Market report?

Ans: The Types covered in the Cell Therapy Manufacturing Market report are Autologous, Allogenic

Recommended Reports

Cell Therapy Manufacturing

Therapy Products & Solutions

Stem Cell & Regenerative

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous
1.2.3 Allogenic
1.3 Market by Application
1.3.1 Global Cell Therapy Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Commercial
1.3.4 Pre-clinical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy Manufacturing Market Perspective (2020-2031)
2.2 Global Cell Therapy Manufacturing Growth Trends by Region
2.2.1 Global Cell Therapy Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Therapy Manufacturing Historic Market Size by Region (2020-2025)
2.2.3 Cell Therapy Manufacturing Forecasted Market Size by Region (2026-2031)
2.3 Cell Therapy Manufacturing Market Dynamics
2.3.1 Cell Therapy Manufacturing Industry Trends
2.3.2 Cell Therapy Manufacturing Market Drivers
2.3.3 Cell Therapy Manufacturing Market Challenges
2.3.4 Cell Therapy Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Therapy Manufacturing Players by Revenue
3.1.1 Global Top Cell Therapy Manufacturing Players by Revenue (2020-2025)
3.1.2 Global Cell Therapy Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Cell Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Therapy Manufacturing Revenue
3.4 Global Cell Therapy Manufacturing Market Concentration Ratio
3.4.1 Global Cell Therapy Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Manufacturing Revenue in 2024
3.5 Global Key Players of Cell Therapy Manufacturing Head office and Area Served
3.6 Global Key Players of Cell Therapy Manufacturing, Product and Application
3.7 Global Key Players of Cell Therapy Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy Manufacturing Breakdown Data by Type
4.1 Global Cell Therapy Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Cell Therapy Manufacturing Forecasted Market Size by Type (2026-2031)
5 Cell Therapy Manufacturing Breakdown Data by Application
5.1 Global Cell Therapy Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Cell Therapy Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Therapy Manufacturing Market Size (2020-2031)
6.2 North America Cell Therapy Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Therapy Manufacturing Market Size by Country (2020-2025)
6.4 North America Cell Therapy Manufacturing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Therapy Manufacturing Market Size (2020-2031)
7.2 Europe Cell Therapy Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Therapy Manufacturing Market Size by Country (2020-2025)
7.4 Europe Cell Therapy Manufacturing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Manufacturing Market Size (2020-2031)
8.2 Asia-Pacific Cell Therapy Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Therapy Manufacturing Market Size (2020-2031)
9.2 Latin America Cell Therapy Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Therapy Manufacturing Market Size by Country (2020-2025)
9.4 Latin America Cell Therapy Manufacturing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy Manufacturing Market Size (2020-2031)
10.2 Middle East & Africa Cell Therapy Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Cell Therapy Manufacturing Introduction
11.1.4 Merck Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Avantor
11.2.1 Avantor Company Details
11.2.2 Avantor Business Overview
11.2.3 Avantor Cell Therapy Manufacturing Introduction
11.2.4 Avantor Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.2.5 Avantor Recent Development
11.3 Cell Therapies
11.3.1 Cell Therapies Company Details
11.3.2 Cell Therapies Business Overview
11.3.3 Cell Therapies Cell Therapy Manufacturing Introduction
11.3.4 Cell Therapies Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.3.5 Cell Therapies Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Cell Therapy Manufacturing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Cell Therapy Manufacturing Introduction
11.5.4 Charles River Laboratories Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.5.5 Charles River Laboratories Recent Development
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent Cell Therapy Manufacturing Introduction
11.6.4 Catalent Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.6.5 Catalent Recent Development
11.7 Bio-Techne
11.7.1 Bio-Techne Company Details
11.7.2 Bio-Techne Business Overview
11.7.3 Bio-Techne Cell Therapy Manufacturing Introduction
11.7.4 Bio-Techne Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.7.5 Bio-Techne Recent Development
11.8 Cytiva
11.8.1 Cytiva Company Details
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Cell Therapy Manufacturing Introduction
11.8.4 Cytiva Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.8.5 Cytiva Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza Cell Therapy Manufacturing Introduction
11.9.4 Lonza Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.9.5 Lonza Recent Development
11.10 BIOCENTRIQ
11.10.1 BIOCENTRIQ Company Details
11.10.2 BIOCENTRIQ Business Overview
11.10.3 BIOCENTRIQ Cell Therapy Manufacturing Introduction
11.10.4 BIOCENTRIQ Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.10.5 BIOCENTRIQ Recent Development
11.11 FUJIFILM Diosynth Biotechnologies
11.11.1 FUJIFILM Diosynth Biotechnologies Company Details
11.11.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.11.3 FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Introduction
11.11.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.11.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Cell Therapy Manufacturing Introduction
11.12.4 Novartis Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.12.5 Novartis Recent Development
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Company Details
11.13.2 Bristol-Myers Squibb Business Overview
11.13.3 Bristol-Myers Squibb Cell Therapy Manufacturing Introduction
11.13.4 Bristol-Myers Squibb Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.13.5 Bristol-Myers Squibb Recent Development
11.14 Gilead
11.14.1 Gilead Company Details
11.14.2 Gilead Business Overview
11.14.3 Gilead Cell Therapy Manufacturing Introduction
11.14.4 Gilead Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.14.5 Gilead Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Details
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Cell Therapy Manufacturing Introduction
11.15.4 WuXi AppTec Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.15.5 WuXi AppTec Recent Development
11.16 Pharmaron
11.16.1 Pharmaron Company Details
11.16.2 Pharmaron Business Overview
11.16.3 Pharmaron Cell Therapy Manufacturing Introduction
11.16.4 Pharmaron Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.16.5 Pharmaron Recent Development
11.17 Aldevron
11.17.1 Aldevron Company Details
11.17.2 Aldevron Business Overview
11.17.3 Aldevron Cell Therapy Manufacturing Introduction
11.17.4 Aldevron Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.17.5 Aldevron Recent Development
11.18 Exothera
11.18.1 Exothera Company Details
11.18.2 Exothera Business Overview
11.18.3 Exothera Cell Therapy Manufacturing Introduction
11.18.4 Exothera Revenue in Cell Therapy Manufacturing Business (2020-2025)
11.18.5 Exothera Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell Therapy Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Autologous
 Table 3. Key Players of Allogenic
 Table 4. Global Cell Therapy Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cell Therapy Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell Therapy Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cell Therapy Manufacturing Market Share by Region (2020-2025)
 Table 8. Global Cell Therapy Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cell Therapy Manufacturing Market Share by Region (2026-2031)
 Table 10. Cell Therapy Manufacturing Market Trends
 Table 11. Cell Therapy Manufacturing Market Drivers
 Table 12. Cell Therapy Manufacturing Market Challenges
 Table 13. Cell Therapy Manufacturing Market Restraints
 Table 14. Global Cell Therapy Manufacturing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cell Therapy Manufacturing Market Share by Players (2020-2025)
 Table 16. Global Top Cell Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2024)
 Table 17. Ranking of Global Top Cell Therapy Manufacturing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cell Therapy Manufacturing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cell Therapy Manufacturing, Headquarters and Area Served
 Table 20. Global Key Players of Cell Therapy Manufacturing, Product and Application
 Table 21. Global Key Players of Cell Therapy Manufacturing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cell Therapy Manufacturing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cell Therapy Manufacturing Revenue Market Share by Type (2020-2025)
 Table 25. Global Cell Therapy Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cell Therapy Manufacturing Revenue Market Share by Type (2026-2031)
 Table 27. Global Cell Therapy Manufacturing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cell Therapy Manufacturing Revenue Market Share by Application (2020-2025)
 Table 29. Global Cell Therapy Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cell Therapy Manufacturing Revenue Market Share by Application (2026-2031)
 Table 31. North America Cell Therapy Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cell Therapy Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cell Therapy Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cell Therapy Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cell Therapy Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cell Therapy Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cell Therapy Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cell Therapy Manufacturing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cell Therapy Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cell Therapy Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cell Therapy Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cell Therapy Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cell Therapy Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Merck Company Details
 Table 47. Merck Business Overview
 Table 48. Merck Cell Therapy Manufacturing Product
 Table 49. Merck Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 50. Merck Recent Development
 Table 51. Avantor Company Details
 Table 52. Avantor Business Overview
 Table 53. Avantor Cell Therapy Manufacturing Product
 Table 54. Avantor Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 55. Avantor Recent Development
 Table 56. Cell Therapies Company Details
 Table 57. Cell Therapies Business Overview
 Table 58. Cell Therapies Cell Therapy Manufacturing Product
 Table 59. Cell Therapies Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 60. Cell Therapies Recent Development
 Table 61. Thermo Fisher Scientific Company Details
 Table 62. Thermo Fisher Scientific Business Overview
 Table 63. Thermo Fisher Scientific Cell Therapy Manufacturing Product
 Table 64. Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 65. Thermo Fisher Scientific Recent Development
 Table 66. Charles River Laboratories Company Details
 Table 67. Charles River Laboratories Business Overview
 Table 68. Charles River Laboratories Cell Therapy Manufacturing Product
 Table 69. Charles River Laboratories Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 70. Charles River Laboratories Recent Development
 Table 71. Catalent Company Details
 Table 72. Catalent Business Overview
 Table 73. Catalent Cell Therapy Manufacturing Product
 Table 74. Catalent Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 75. Catalent Recent Development
 Table 76. Bio-Techne Company Details
 Table 77. Bio-Techne Business Overview
 Table 78. Bio-Techne Cell Therapy Manufacturing Product
 Table 79. Bio-Techne Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 80. Bio-Techne Recent Development
 Table 81. Cytiva Company Details
 Table 82. Cytiva Business Overview
 Table 83. Cytiva Cell Therapy Manufacturing Product
 Table 84. Cytiva Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 85. Cytiva Recent Development
 Table 86. Lonza Company Details
 Table 87. Lonza Business Overview
 Table 88. Lonza Cell Therapy Manufacturing Product
 Table 89. Lonza Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 90. Lonza Recent Development
 Table 91. BIOCENTRIQ Company Details
 Table 92. BIOCENTRIQ Business Overview
 Table 93. BIOCENTRIQ Cell Therapy Manufacturing Product
 Table 94. BIOCENTRIQ Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 95. BIOCENTRIQ Recent Development
 Table 96. FUJIFILM Diosynth Biotechnologies Company Details
 Table 97. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 98. FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Product
 Table 99. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 100. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 101. Novartis Company Details
 Table 102. Novartis Business Overview
 Table 103. Novartis Cell Therapy Manufacturing Product
 Table 104. Novartis Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 105. Novartis Recent Development
 Table 106. Bristol-Myers Squibb Company Details
 Table 107. Bristol-Myers Squibb Business Overview
 Table 108. Bristol-Myers Squibb Cell Therapy Manufacturing Product
 Table 109. Bristol-Myers Squibb Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 110. Bristol-Myers Squibb Recent Development
 Table 111. Gilead Company Details
 Table 112. Gilead Business Overview
 Table 113. Gilead Cell Therapy Manufacturing Product
 Table 114. Gilead Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 115. Gilead Recent Development
 Table 116. WuXi AppTec Company Details
 Table 117. WuXi AppTec Business Overview
 Table 118. WuXi AppTec Cell Therapy Manufacturing Product
 Table 119. WuXi AppTec Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 120. WuXi AppTec Recent Development
 Table 121. Pharmaron Company Details
 Table 122. Pharmaron Business Overview
 Table 123. Pharmaron Cell Therapy Manufacturing Product
 Table 124. Pharmaron Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 125. Pharmaron Recent Development
 Table 126. Aldevron Company Details
 Table 127. Aldevron Business Overview
 Table 128. Aldevron Cell Therapy Manufacturing Product
 Table 129. Aldevron Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 130. Aldevron Recent Development
 Table 131. Exothera Company Details
 Table 132. Exothera Business Overview
 Table 133. Exothera Cell Therapy Manufacturing Product
 Table 134. Exothera Revenue in Cell Therapy Manufacturing Business (2020-2025) & (US$ Million)
 Table 135. Exothera Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Cell Therapy Manufacturing Picture
 Figure 2. Global Cell Therapy Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell Therapy Manufacturing Market Share by Type: 2024 VS 2031
 Figure 4. Autologous Features
 Figure 5. Allogenic Features
 Figure 6. Global Cell Therapy Manufacturing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cell Therapy Manufacturing Market Share by Application: 2024 VS 2031
 Figure 8. Clinical Case Studies
 Figure 9. Commercial Case Studies
 Figure 10. Pre-clinical Case Studies
 Figure 11. Cell Therapy Manufacturing Report Years Considered
 Figure 12. Global Cell Therapy Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Cell Therapy Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cell Therapy Manufacturing Market Share by Region: 2024 VS 2031
 Figure 15. Global Cell Therapy Manufacturing Market Share by Players in 2024
 Figure 16. Global Top Cell Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Cell Therapy Manufacturing Revenue in 2024
 Figure 18. North America Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Cell Therapy Manufacturing Market Share by Country (2020-2031)
 Figure 20. United States Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cell Therapy Manufacturing Market Share by Country (2020-2031)
 Figure 24. Germany Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cell Therapy Manufacturing Market Share by Region (2020-2031)
 Figure 32. China Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cell Therapy Manufacturing Market Share by Country (2020-2031)
 Figure 40. Mexico Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cell Therapy Manufacturing Market Share by Country (2020-2031)
 Figure 44. Turkey Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Cell Therapy Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Merck Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 48. Avantor Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 49. Cell Therapies Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 51. Charles River Laboratories Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 52. Catalent Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 53. Bio-Techne Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 54. Cytiva Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 55. Lonza Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 56. BIOCENTRIQ Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 57. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 58. Novartis Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 60. Gilead Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 61. WuXi AppTec Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 62. Pharmaron Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 63. Aldevron Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 64. Exothera Revenue Growth Rate in Cell Therapy Manufacturing Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture